| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/02/2006 | US20060024656 Method of making bone particles |
| 02/02/2006 | US20060024380 Chemical cleaning of biological material |
| 02/02/2006 | US20060024377 Composite materials for controlled release of water soluble products |
| 02/02/2006 | US20060024373 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 02/02/2006 | US20060024318 Vaccination with immuno-isolated cells producing an immunomodulator |
| 02/02/2006 | US20060024312 Methods for enhancing learning and memory |
| 02/02/2006 | US20060024299 Human osteoclast derived cathepsin |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024280 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
| 02/02/2006 | US20060024279 Retroviral vectors |
| 02/02/2006 | US20060024275 Methods for use of MPL ligands with primitive human stem cells |
| 02/02/2006 | US20060024274 Retroviral vectors |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024249 Methods and compositions for bioengineering a tooth |
| 02/02/2006 | DE19856463B4 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors |
| 02/02/2006 | CA2616277A1 Urine markers for detection of bladder cancer |
| 02/02/2006 | CA2579753A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 02/02/2006 | CA2579674A1 Method for preventing dehiscence and altering plant lignification |
| 02/02/2006 | CA2575516A1 Method of three-dimensionally culturing chondrocytes |
| 02/02/2006 | CA2574654A1 Compositions and methods of use for mgd-csf in disease treatment |
| 02/02/2006 | CA2574499A1 Process for enriching a population of sperm cells |
| 02/02/2006 | CA2573768A1 Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells |
| 02/02/2006 | CA2573018A1 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 02/02/2006 | CA2571426A1 Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (trail) |
| 02/02/2006 | CA2570491A1 Method to decrease the rate of polyspermy in ivf |
| 02/01/2006 | EP1621635A2 Self-assembling recombinant HP16 papillomavirus capsid proteins |
| 02/01/2006 | EP1621633A2 Glycoproteins produced in plants with suppressed expression of beta 1, 2-xylosyltransferase |
| 02/01/2006 | EP1621630A1 Method for preventing dehiscence and altering plant lignification |
| 02/01/2006 | EP1621627A2 Use of porcine gala (1,3) galactosyl transferase in xenograft therapies |
| 02/01/2006 | EP1621624A1 Genes for lysine biosynthetic system derived from thermophilic bacteria |
| 02/01/2006 | EP1621623A2 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitis |
| 02/01/2006 | EP1621619A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2006 | EP1621618A1 Cell concentration and lysate clearance using paramagnetic particles |
| 02/01/2006 | EP1621611A1 Tongue epithelium-origin cell line kt-1 and use thereof |
| 02/01/2006 | EP1621610A1 A method of producing nuclear transfer embryonic stem cell by somatic cell nuclear transplantation technique |
| 02/01/2006 | EP1621550A1 Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) |
| 02/01/2006 | EP1621548A2 Polypeptides, CDNAs encoding the same and utilization thereof |
| 02/01/2006 | EP1621218A1 Auologous bone graft material |
| 02/01/2006 | EP1621207A2 Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors |
| 02/01/2006 | EP1621082A2 Process and an enzyme for use in such a process |
| 02/01/2006 | EP1620562A2 Modulation of telomere-initiated cell signaling |
| 02/01/2006 | EP1620558A1 Viral vectors expressing fusion of viral large envelope protein and protein of interest |
| 02/01/2006 | EP1620550A2 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 02/01/2006 | EP1620549A1 Process for the production of biological substances by perfusion culturing of suspended animal cells |
| 02/01/2006 | EP1620545A2 Disease prevention and vaccination following thymic reactivation |
| 02/01/2006 | EP1620538A2 Trasngenic expression of a phytochrome a gene |
| 02/01/2006 | EP1620459A2 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 02/01/2006 | EP1620457A2 Inducers of recombinant protein expression |
| 02/01/2006 | EP1620126A2 Disease prevention and vaccination prior to thymic reactivations |
| 02/01/2006 | EP1620125A2 Tolerance to graft following thymic reactivation |
| 02/01/2006 | EP1620112A2 Desmoglein 4 is a novel gene involved in hair growth |
| 02/01/2006 | EP1619952A2 Tolerance to graft prior to thymic regeneration |
| 02/01/2006 | EP1619949A2 Postnatal stem cells and uses thereof |
| 02/01/2006 | EP1619945A2 Improved methods and solutions for storing donor organs |
| 02/01/2006 | EP1592790A4 Electromagnetic activation of gene expression and cell growth |
| 02/01/2006 | EP1471788A4 Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells |
| 02/01/2006 | EP1434887A4 Method of isolating cells and uses thereof |
| 02/01/2006 | EP1409662B1 Allene oxide synthase and divinyl ether synthase from the cyp74-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method for producing pathogen-resistant plants |
| 02/01/2006 | EP1223953B1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 02/01/2006 | EP1200479B1 Multiple cytokine-antibody complexes |
| 02/01/2006 | EP1196566B1 Expression vectors and methods |
| 02/01/2006 | EP1185636B1 METHODS FOR DISPLAY OF HETERODIMERIC PROTEINS ON FILAMENTOUS PHAGE USING pVII and pIX, COMPOSITIONS, VECTORS AND COMBINATORIAL LIBRARIES |
| 02/01/2006 | EP1179592B1 Proteins nectin-3 |
| 02/01/2006 | EP1129204B1 Novel system for regulating transgene expression |
| 02/01/2006 | EP1115849B1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 02/01/2006 | EP1100928B1 Bifunctional enzymes for biopolymer production |
| 02/01/2006 | EP1066052B1 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 02/01/2006 | EP1062350B1 Transgenic crops accumulating fructose polymers and methods for their production |
| 02/01/2006 | EP0907736B1 Cc-type chemokines |
| 02/01/2006 | EP0809703B1 Methods for maintaining sterility in plants |
| 02/01/2006 | EP0264434B2 Detection of a unique chlamydia strain associated with acute respiratory disease |
| 02/01/2006 | CN2755098Y Plant cell wall breaker |
| 02/01/2006 | CN1729292A DNA sequences from tcd genomic region of photorhabdus luminescens |
| 02/01/2006 | CN1729290A Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
| 02/01/2006 | CN1729288A Novel nitrile hydratase |
| 02/01/2006 | CN1729285A Artificial synapse chip interface for electronic prosthetic retina |
| 02/01/2006 | CN1729203A Human monoclonal antibodies against CD20 |
| 02/01/2006 | CN1729008A Delocalization molecules and use thereof |
| 02/01/2006 | CN1728946A Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 02/01/2006 | CN1728941A Generation of plants with altered oil content |
| 02/01/2006 | CN1727490A Method for breeding halophyte of double transgene |
| 02/01/2006 | CN1727485A Highly expressed cotton ag2 gene possessing resistance on adversity induced by glyphosate |
| 02/01/2006 | CN1727484A Expressed ag2 promotor in cotton inducted by glyphosate |
| 02/01/2006 | CN1727473A Technique for freezing bare embryo |
| 02/01/2006 | CN1727472A A simple method for separating and purifying stem cell of cranial nerve |
| 02/01/2006 | CN1727471A Application of alcohol soluble film in protein ground substance from source of plants |
| 02/01/2006 | CN1727362A Preparation and application of vaccine for curing tumor in positive carcino-embryonic antigen |
| 02/01/2006 | CN1727359A Compound from catarrh mollase bacterial |
| 02/01/2006 | CN1239704C Gene associated with plant salt resistance and drought resistance, encoded protein and application thereof |
| 02/01/2006 | CN1239702C Rice root system phosphorus starvation induction specific expression promoter and its plant culture method |
| 02/01/2006 | CN1239701C Humanised antibodies to epidermal growth factor receptor |
| 02/01/2006 | CN1239699C Method for construction of bombyx mori virus fast gene expression system utilizing bacterium transposon |
| 02/01/2006 | CN1239691C Device and method for cultivation |
| 01/31/2006 | US6992240 Soybean variety XB31W05 |
| 01/31/2006 | US6992239 Soybean variety 92M61 |
| 01/31/2006 | US6992236 Modification of the expression of UDP-glucose 4-epimerase may result in grains with reduced fiber and increased levels of starch thus adding value for feed, food, and industrial applications of crops |
| 01/31/2006 | US6992235 Method for marker-free repetitive DNA expression cassette exchange in the genome of cells or parts of cells |
| 01/31/2006 | US6992181 separation of deoxyribonucleic acids from cells using discs comprising microstructure channels having bead selected from polymers, metal oxides, glass or carbon; lysis |
| 01/31/2006 | US6992178 conferred to cultured animal cells and various tissues in the living bodies; contains a lectin; kits |
| 01/31/2006 | US6992177 haptens comprising protease inhibitors such as succinimido-oxycarbonyl-ethylamino-glycyl-glycyl-glutaryl-aminomethyl-(pyr)saquinavir conjugates with hemocyanins, albumin or dextran, used to generate antibodies and immunogens to saquinavir; assays |